Zürcher Kantonalbank Discloses Position in Avadel Pharmaceuticals

Zürcher Kantonalbank has disclosed its position in Avadel Pharmaceuticals, following Irish Takeover Panel regulations. As of January 13, 2026, the bank holds interests in 1,510,006 ordinary shares of Avadel, representing a 1.55% stake. This disclosure is made under Rule 8.3 of the Irish Takeover Panel Act, 1997. Zürcher Kantonalbank does not report interests in any other party involved in an offer, nor are there any short positions to disclose.

All disclosed securities are ordinary shares, with no involvement in cash-settled or stock-settled derivatives. Furthermore, no new securities transactions or dealing arrangements related to indemnity or options have been undertaken by the bank. Zürcher Kantonalbank confirms no agreements concerning voting rights or securities disposal are in place.